SCHEMBL9873534

SCHEMBL9873534

CCc1nnc(CC)c2c1nc(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9873079 0.93 PPARG (0.51) PPARG
SCHEMBL9874410 0.88 PPARG (0.52) PPARG
SCHEMBL9874759 0.87 PPARG (0.49) PPARG
SCHEMBL9873381 0.85 AGTR2 (0.66)
SCHEMBL9871745 0.85 PPARG (0.56) PPARG
SCHEMBL9873573 0.85 PPARG (0.52) PPARG
SCHEMBL9874062 0.85 PPARG (0.54) PPARG
SCHEMBL9872887 0.83 PPARG (0.49) PPARG
SCHEMBL9871788 0.83 PPARG (0.52) PPARG
SCHEMBL9874055 0.83 AGTR1 (0.53) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed